Southern States Lag Behind North in Drop in Colon Cancer
THURSDAY, July 7 (HealthDay News) -- While there has been a
significant decline in colon cancer death rates in the past two
decades, a new report reveals that the downward trend is not spread
evenly across the United States, with the southern part of the
nation lagging far behind the north.
Focusing on the time period between 1990 and 2007, the current
study found that in certain instances the growing regional gap is
quite dramatic: ranging from no drop whatsoever in colon cancer
mortality rates in the southern state of Mississippi to a 33
percent plummet in colon cancer deaths across the northern states
of Massachusetts, Rhode Island, New York and Alaska.
"There is certainly a clear regional disparity in colorectal cancer death rates in the U.S.," noted study co-author Ahmedin Jemal, vice president for surveillance research at the American Cancer Society. "And there are several factors that might contribute to this."
"One factor may be colorectal screening rates, state-by-state," Jemal observed, "with indications of a much lower utilization of screenings in the southern states. And secondly, although we didn't collect data on treatment for colorectal cancer by states, we already know from previous studies that those who live in poorer neighborhoods and more rural areas are less likely to have insurance coverage, and less likely to receive standard treatment for colorectal cancer."
"And the third factor," he added, "is that smoking and obesity are known risk factors for colorectal cancer. And for both prevalence is much higher in the southern states, compared to other regions."
Jemal and his colleagues report their findings in the July issue
Cancer Epidemiology, Biomarkers & Prevention.
According to a separate report issued by the U.S. Centers for
Disease Control and Prevention earlier this week, declining colon
cancer death rates have not stripped the disease of its deadly
status. The CDC report noted that it currently ranks second among
cancers as a killer of American men and women, and the American
Cancer Society (ACS) report characterizes it as the nation's number
three cancer killer.
Part of the continuing problem, according to the CDC, is that
despite the availability of highly effective screening techniques,
only two-thirds of Americans got tested for the disease in 2010.
And although that figure represents a significant jump in screening
rates (52 percent to 65 percent), 22 million men and women still
did not get screened.
However, the CDC noted that colon cancer death rates have
nonetheless plunged dramatically.
To dig a little deeper into how that breaks down state by state,
the ACS authors analyzed 17 years of information reported by the
National Center for Health Statistics.
The bottom line: Overall, the northeast saw a far greater drop
in colorectal death rates than did the south.
For example, the team noted that northern states such as New
York and Massachusetts saw their decline in colorectal cancer death
rates pick up significant speed over the study period, from an
annual drop of 2.5 percent n the 1990s to a annual drop of between
4 percent and 5 percent in the 2000s.
By contrast, southern states like Mississippi and Alabama saw
their annual death rates remain more or less constant over the same
Interestingly, the researchers found that over the study period
the highest colorectal cancer death rates migrated. While the
highest death rates had been found among northeastern states in the
1990s, by the mid-2000s the highest death rates were in states in
the Appalachian corridor.
To get at what might be driving these state-by-state trends,
Jemal and his associates stressed the marked regional differences
in insurance coverage. For example, U.S. Census Bureau numbers for
2007 revealed that while nearly 19 percent of Mississippians and
Louisianans lacked coverage at the time, that figure was just 5.4
percent in Massachusetts.
What's more, while the national poverty rate currently hovers at
about 13 percent, that figure shoots up to one in five in
In terms of the prevalence of notable disease risk factors, the
South has been less quick to kick the smoking habit than either the
Northwest or West, the study authors noted, while obesity remains a
greater issue in the South than in other regions of the
Dr. Felice Schnoll-Sussman, director of research at the Jay
Monahan Center for Gastrointestinal Health at New York-Presbyterian
Hospital/Weill Cornell Medical Center in New York City, said that
while such underlying explanations "make sense," the findings are
both "surprising" and "shocking."
"You might expect there might be some difference in the death rate between, say, a state like New York where you can bump into a physician at every corner, and other places where there aren't as many," she said. "You'd think we'd find maybe a 5 or 10 percent difference. But for there to be such a large difference is really what is so shocking and sad."
"And it's really unacceptable," Schnoll-Sussman added. "Because we have already made great strides in getting the word out that colorectal cancer is identifiable and treatable. So, I would say that this study isn't so much focused on trying to answer the question as to why this is happening as it is highlighting a call for action to try and make a difference for those patients for whom likely economic disparities are playing a huge role in all of this. So we need to continue to focus on access to care, education of the patient, education of the internists, open access to endoscopy and bringing down barriers related to the fear of having a screening done. That's where we can make an impact. That's where we can make a difference."
For more on colorectal cancer statistics, visit the
U.S. Centers for Disease Control and
Copyright © 2011
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.